Found 51 matching trials
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer PHASE3 The PREOPANC-3 study is a randomized, multicenter, phase 3 trial. Patients ...
Show More Status
Active Not Recruiting
Location
Jeroen Bosch Hospital
Learn More & Join Trial
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer PHASE2 Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Show More Location
Baylor College of Medicine
Learn More & Join Trial
A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC) NA Pancreatic cancer exhibits significant heterogeneity, which poses a major c...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma PHASE2 Surgical resection is the only potentially curative treatment for patients ...
Show More Location
Smilow Cancer Hospital
Learn More & Join Trial
A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer PHASE1 The study is being conducted to: a) evaluate the tolerability and safety of...
Show More Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy. PHASE3 The main purpose of
* To observe the overall survival of patients with res...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer PHASE1 The researchers are doing this study to find out whether ELI-002 7P in comb...
Show More Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) PHASE3 The main aim of this study is to compare the efficacy of short-course versu...
Show More Status
Active Not Recruiting
Location
Oncologia Medica e Prevenzione Oncologica Centro di riferimento oncologico (CRO), IRCCS
Learn More & Join Trial